Aleksander Krag

Active 2007–2026

177
Papers
21,579
Citations
69
h-index
160
i10-index

Citations

Citations per year for Aleksander Krag2001: 1 citations2004: 1 citations2008: 1 citations2009: 5 citations2010: 12 citations2011: 8 citations2012: 26 citations2013: 17 citations2014: 28 citations2015: 55 citations2016: 49 citations2017: 60 citations2018: 91 citations2019: 410 citations2020: 565 citations2021: 737 citations2022: 831 citations2023: 899 citations2024: 1,842 citations2025: 1,209 citations2026: 71 citations2002–2003: no citations, so these years are not shown2005–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,306 citing papers, 14% of this breakdownChina: 1,068 citing papers, 11.5% of this breakdownItaly: 616 citing papers, 6.6% of this breakdownGermany: 603 citing papers, 6.5% of this breakdownUnited Kingdom: 590 citing papers, 6.3% of this breakdownSpain: 516 citing papers, 5.5% of this breakdownFrance: 370 citing papers, 4% of this breakdownDenmark: 363 citing papers, 3.9% of this breakdownCanada: 293 citing papers, 3.2% of this breakdownIndia: 244 citing papers, 2.6% of this breakdownSwitzerland: 212 citing papers, 2.3% of this breakdownAustria: 210 citing papers, 2.3% of this breakdown
0%14%Other 31.3%

Fields

  • Medicine84.5%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology1.3%
  • Chemistry0.9%
  • Environmental Science0.6%
  • Engineering0.6%
  • Other2.2%

Topics

  • Liver Disease Diagnosis and Treatment19.1%
  • Liver Disease and Transplantation16.6%
  • Organ Transplantation Techniques and Outcomes4.6%
  • Hepatocellular Carcinoma Treatment and Prognosis3.1%
  • Alcohol Consumption and Health Effects3%
  • Liver physiology and pathology2.8%
  • Other50.8%

Coauthors

All papers

Open in search
  1. Baveno VII – Renewing consensus in portal hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji - Journal of Hepatology 2021 cited by 2,669

  2. Liver cirrhosis

    Authors: , , , , , - The Lancet 2021 cited by 1,501

  3. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

    Authors: , , , , , , , , - Journal of Hepatology 2018 cited by 2,848

  4. Noninvasive proteomic biomarkers for alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 320

  5. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2023 cited by 215

  6. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

    Authors: , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2024 cited by 153

  7. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 276

  8. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eva Bonfill, Marta Juan, Anna Sòria, Marta Carol, Jordi Gratacós‐Ginès, Rosa M. Morillas, Pere Torán‐Monserrat, J. M. Navarrete, Antoni Torrejón, Céline Fournier, Anne Llorca, Anita Arslanow, Harry J de Koning, Fernando Cucchietti, Michael P. Manns, Philip N. Newsome, Rubén Hernáez, Alina M. Allen, Paolo Angeli, Robert J. de Knegt, Tom H. Karlsen, Peter R. Galle, Vincent Wai‐Sun Wong, Núria Fabrellas, Laurent Castéra, Aleksander Krag, Frank Lammert, Patrick S Kamath, Pere Ginès, Marifé Alvarez, Peter Andersen, Paolo Angeli, Alba Ardèvol, Anita Arslanow, Luca Beggiato, Zahia Ben Abdesselam, Lucy Bennett, Bajiha Boutouria, Alessandra Brocca, M. Teresa Broquetas, M. Teresa Broquetas, Valeria Calvino, Judith Camacho, Aura Capdevila, Marta Carol, Laurent Castéra, Marta Cervera, Marta Cervera, Anna de Fuentes, Rob de Knegt, Rob de Knegt, Sönke Detlefsen, Alba Díaz, José Diéguez Bande, Vanessa Esnault, Núria Fabrellas, Josep Lluis Falcó, Rosa Fernández, Céline Fournier, Céline Fournier, Peter R. Galle, Edgar García, Montserrat Garcı́a-Retortillo, E.A González Garrido, Pere Ginès, Rosa Gordillo Medina, Jordi Gratacós‐Ginès, Isabel Graupera, Jordi Gratacós-Ginès, Indra Neil Guha and 78 more - The Lancet 2023 cited by 157

  9. EASL Clinical Practice Guidelines on acute-on-chronic liver failure

    Authors: , , , , , , , , , , , - Journal of Hepatology 2023 cited by 317

  10. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 289

  11. Steatotic liver disease

    Authors: , , , - The Lancet 2024 cited by 298

  12. A global research priority agenda to advance public health responses to fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Veronica Miller, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C. Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham and 241 more - Journal of Hepatology 2023 cited by 132

  13. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Boyer, М. V. Maevskaya, E Fassio, Hyoung Su Kim, Jae Seok Hwang, Pere Ginès, Adrián Gadano, Shiv Kumar Sarin, Paolo Angeli, Michele Bartoletti, Carlos Brodersen, Tony Bruns, Robert A. de Man, Annette Dam Fialla, Carmine Gambino, Vikas Gautam, Marcos Girala, Adrià Juanola, Jeong Han Kim, Tae Hun Kim, Pramod Kumar, Barbara Lattanzi, Tae Hee Lee, Cosmas A. Rinaldi Lesmana, Richard Moreau, Preetam Nath, Gustavo Navarro, Ji Won Park, Gisela Pinero, Nikolaos Pyrsopoulos, Sophie Restellini, Gustavo Romero, M. Sacco, Tiago Sevá‐Pereira, Macarena Simón‐Talero, Do Seon Song, Ki Tae Suk, Hans Van Vlierberghe, Sun Young Yim, Eileen L. Yoon, Giacomo Zaccherini - Gastroenterology 2018 cited by 501

  14. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johannes Wiegand, Thomas Karlas - ˜The œLancet. Gastroenterology & hepatology 2021 cited by 256

  15. Examining the healthy human microbiome concept

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jens Walter, Bo Yang, Natalia Yutin, Alexandra Zhernakova, Hub Zwart, Francesco Asnicar, Athanasios Typas, Fay Betsou, Hervé Blottière, Peer Bork, Isabelle Boutron, Federica Carraturo, Marcus Claesson, Magali Cordaillat-Simmons, Celine Druart, Alessio Fasano, Yolanda Godoy, Dirk Haller, Zahra Hassani, Diënty H. M. J. Hazenbrink, Mads Israelsen, Anandhi Iyappan, Alexander Jarde, Stephan Kampshoff, Aleksander Krag, Aicha Kriaa, Aonghus Lavelle, Amira Metwaly, Vitalina Morozova, Federica Pinto, Nicolas Pons, Pierre-Louis Prost, Philippe Ravaud, Moez Rhimi, Julie Rodriguez, Arjun Sarati, Robert Schierwagen, Nicola Segata, Debora Serra, Jonel Trebicka, Corrado Vecchi, Patrick Veiga, Laurence Zitvogel, Lisa Derosa, Joël Doré, R. Paul Ross - Nature Reviews Microbiology 2024 cited by 139

  16. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 207

  17. Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2022 cited by 110

  18. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure

    Authors: , , , - Nature Reviews Gastroenterology & Hepatology 2020 cited by 191

  19. A global action agenda for turning the tide on fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Norah A. Terrault, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, on behalf of the Healthy Livers, Healthy Lives Collaborators - Hepatology 2023 cited by 90

  20. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease

    Authors: , , , , , - Gastroenterology 2018 cited by 269

  21. MetALD: new opportunities to understand the role of alcohol in steatotic liver disease

    Authors: , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 72

  22. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 141

  23. Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mireen Friedrich‐Rust - Hepatology 2017 cited by 468

  24. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    Authors: , , , , , , , , , , , , , , , , , - Hepatology 2018 cited by 257